Microbial Genomics Group
We are a research group working on evolutionary genomics of infectious bacteria and viruses. We use bioinformatics to learn from microbial evolution, thus helping design better medical interventions against infections.
About us
Our motivation
Bacteria are incredibly diverse and adaptable. This makes them exciting, but also problematic when they cause diseases. One notable example is resistance to antibiotics: as a result of excessive drug use, bacteria with the capacity to resist the action of antibiotics have been outcompeting other bacteria. As we are currently running out of antibiotics, we need novel weapons against these “superbugs”. But new weapons are not enough – bacteria will eventually overcome them too. Hence, we also need to understand how bugs adapt to these weapons and use them wisely.
“Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.”
— prof. dame sally davies, England’s chief medical officer
Our research
In our lab, we study bacterial surface structures called capsules and lipopolysaccharides. These molecules are made of highly diverse sugars and, as was shown, are able to evolve quickly. Incidentally, these sugars are targets of many novel biotechnological approaches to fight opportunistic bacterial infections which do not respond to antibiotics: glycoconjugate vaccines, immunotherapies or phage-based treatments. These surface structures have likely been co-evolving with the host immune system and phages for millions of years. Hence, we need to learn more about these interactions to understand the full potential of future medical interventions targeted at bacterial surface sugars.
Our philosophy
Our group is interested in fundamental biological and evolutionary questions that are also relevant for medicine. We strongly believe in the importance of transparency and reproducibility of our research, in accordance with the Open Science movement. For this reason, we prioritise publishing in Open Access scientific journals and are eager to publicise the code developed for the data analyses. We are committed to equal opportunities and do not discriminate against gender, race nor religious background.
Stay up to date
-
RT @AdamGudys: Thinking of aligning a million of sequences? Take a look at our @COSB_CRSB review on ultra-scale protein sequence a… https://t.co/YsEdtHSSqe
-
RT @FranSupek: 🇪🇸❓What's happening within Spain? 🔥Catalonia ~= Sweden 👍Basque Country > than Germany and UK Madrid, Valencia ~= C… https://t.co/LAvv14CqUU
-
RT @thesteinegger: Check out the latest preprint from @janani_hex, @Joana_MPereira & team, where they delve into the AlphaFold databas… https://t.co/365BBfUr4A
-
RT @Phages_fr: Contrats to Cécile Breyton and collaborators !! First structure of the complex between a phage RBP and its Receptor… https://t.co/AuZaCRqXEY
-
RT @thesteinegger: For those interested in exploring the structural space using Foldseek, check out the tutorial video from @SBGrid, w… https://t.co/H1qpDEMZKI